The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

GSK Drugs

Forums General Melanoma Community GSK Drugs

  • Post
    mrf
    Keymaster

    GSK just submitted an application to the FDA for their two new melanoma drugs to be used in combination.  This is a BRAF inhibitor, dabrafenib, and a MEK inhibitor, trametinib.  Studies have shown that these drugs work better in combination than either do alone.  I think most people expected they would be prescribed in combination, but getting this approval, if it is approved, will help smooth conversations about off-label usage and reimbursement.

    GSK just submitted an application to the FDA for their two new melanoma drugs to be used in combination.  This is a BRAF inhibitor, dabrafenib, and a MEK inhibitor, trametinib.  Studies have shown that these drugs work better in combination than either do alone.  I think most people expected they would be prescribed in combination, but getting this approval, if it is approved, will help smooth conversations about off-label usage and reimbursement.

    http://www.gsk.com/media/press-releases/2013/GSK-announces-US-submission-for-dabrafenib-trametinib-combination-in-metastatic-melanoma.htmlTim–MRF

    Tim–MRF

Viewing 3 reply threads
  • Replies
      POW
      Participant

      That is teriffic news, Tim! Thank you! 

      Is there anything we can do to assist or speed the approval process? Write to the FDA? Check with our insurance companies to find out if they will pay for the simulatneous administration of both drugs if the combo is NOT FDA approved? (A strong inducement to approve the combo, in my opinion.) Anything?

      POW
      Participant

      That is teriffic news, Tim! Thank you! 

      Is there anything we can do to assist or speed the approval process? Write to the FDA? Check with our insurance companies to find out if they will pay for the simulatneous administration of both drugs if the combo is NOT FDA approved? (A strong inducement to approve the combo, in my opinion.) Anything?

      POW
      Participant

      That is teriffic news, Tim! Thank you! 

      Is there anything we can do to assist or speed the approval process? Write to the FDA? Check with our insurance companies to find out if they will pay for the simulatneous administration of both drugs if the combo is NOT FDA approved? (A strong inducement to approve the combo, in my opinion.) Anything?

      Tim–MRF
      Guest

      Good question.  I think in this case it is a slam dunk–the data is pretty clear.  Let's hold off the letter writing for something that might need a push, such as some of the PD-1 issues we are likely to face in the next months.

      Tim–MRF

      Tim–MRF
      Guest

      Good question.  I think in this case it is a slam dunk–the data is pretty clear.  Let's hold off the letter writing for something that might need a push, such as some of the PD-1 issues we are likely to face in the next months.

      Tim–MRF

      Tim–MRF
      Guest

      Good question.  I think in this case it is a slam dunk–the data is pretty clear.  Let's hold off the letter writing for something that might need a push, such as some of the PD-1 issues we are likely to face in the next months.

      Tim–MRF

Viewing 3 reply threads
  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Popular Topics